Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Current Leases (2022 - 2025)

Biofrontera has reported Current Leases over the past 4 years, most recently at $332000.0 for Q4 2025.

  • Quarterly results put Current Leases at $332000.0 for Q4 2025, down 39.42% from a year ago — trailing twelve months through Dec 2025 was $332000.0 (down 39.42% YoY), and the annual figure for FY2025 was $332000.0, down 39.42%.
  • Current Leases for Q4 2025 was $332000.0 at Biofrontera, up from $307000.0 in the prior quarter.
  • Over the last five years, Current Leases for BFRIW hit a ceiling of $701000.0 in Q2 2024 and a floor of $307000.0 in Q3 2025.
  • Median Current Leases over the past 4 years was $523000.0 (2022), compared with a mean of $528750.0.
  • Biggest five-year swings in Current Leases: soared 42.56% in 2024 and later plummeted 54.18% in 2025.
  • Biofrontera's Current Leases stood at $498000.0 in 2022, then surged by 38.76% to $691000.0 in 2023, then fell by 20.69% to $548000.0 in 2024, then plummeted by 39.42% to $332000.0 in 2025.
  • The last three reported values for Current Leases were $332000.0 (Q4 2025), $307000.0 (Q3 2025), and $443000.0 (Q2 2025) per Business Quant data.